This site is intended for Healthcare professionals only.

Cardiologists at GB Pant Hospital implant first Indian-Made Artificial Aortic Valve

Cardiologists at GB Pant Hospital implant first Indian-Made Artificial Aortic Valve

New Delhi: Making strides in the government’s Make in India Vision, doctors at GB Pant hospital have successfully implanted the first Indian made artificial aortic valve percutaneously. The procedure was carried by the team under Dr Prof.V.K Trehan, leading international cardiologist and Director Professor, Department of Cardiology, GB Pant hospital..

The implantation came as a part of a clinical trial being conducted at the hospital on the valve. If successful, this is going to create a new hope in poor patients with the damaged aortic valve who are currently devoid of the option given the high cost of imported valved in the market.

The successful implantation of the valve was done by team of cardiologists under Dr.V.K Trehan including Dr Safal, Dr Sanjeev Kathuria on a 74 year male with severe aortic stenosis at a high risk of surgery who presented with breathlessness angina and an episode of syncope. With the implantation of the valve, the patient is now showing positive signs of recovery symptomatically and otherwise.

Dr.V.K Trehan informed that with such implantations, the department at GB Pant Hospital aims to provide the treatment of Aortic stenosis through TAVR bringing it with an affordable reach for high-risk patients at government setup.

Transaortic valve replacement treatment for aortic stenosis is the minimally invasive surgical procedure that repairs the damaged aortic valve. It wedges a replacement valve in aortic valve place and this surgery is called transcatheter aortic valve replacement(TAVR). It was initially introduced as an option for high-risk patients with aortic stenosis who cannot be operated by open heart surgery. The procedure is now more and more available for intermediate risk patients. However, while the procedure has benefits primarily in terms of being minimally invasive, it is extremely costly with the cost of a valve and the procedure going into lakhs.

Aiming to provide a cheaper alternative, Myval is a balloon expandable aortic valve, is being introduced by Meril Lifesciences Pvt.Ltd. The same is under study at G.B Pant Hospital by Dr.Vijay Trehan in a clinical trial involving 100 patients.

The Myval valve is made of Hybrid Honeycomb cell Design Concept and the salient features of the design include:

  • Open cells on upper half to ensure un-jailing of coronary ostia
  • Closed cells on lower half for high radial strength
  • Internal PET stealing cuff for the lower profile and puncture resistance
  • Nickel Cobalt alloy frame for high radial strength and RO
  • The bovine pericardial tri-leaflet valve
  • Extremely PET buffing to minimize para-valvular leaks

The valve is going to create a cheap replacement for the imported valve so that the particular surgery can be made available to the poorer section of the Indian population at an affordable price.

Source: press release

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
  1. This is Good for All Indians

  2. user
    Dr Ashwani Mehta May 17, 2018, 5:37 pm

    Great Going . We must appreciate the self less and deicated work of doctors at Government hospitals .
    Great news because this is a better Indian Product and will be much cheaper than the imported valves

  3. There are investigations required to prove the satisfactory functioning of the replaced valve so that documentation of the efficient working of the valve is done . The working only does not include opening and closure of the said valve .The working includes the attainment of the improved functioning of LVEF , No out flow obstruction , Maintenance of good cardiac out put . For that the proper selection of the patient is important which should not be in LVF ,CCF , . Doing a procedure for the sake of procedure is not appreciated . longevity of the patient has value . If dies after a little time only then it does not mean any thingh . Therefore such procedures should be attempted in compensated hearts only . Cases or procedures can be highlighted after pt. responses are assessed for 5yrs and then highlighted .

  4. user
    Neeraj Pandit May 16, 2018, 5:24 pm

    Congratulations to the pioneers from India

  5. user
    Vimal Kumar jain May 16, 2018, 4:54 pm

    Excellent development,certainly relief for many (Economically Strained patients) high risk cases of Aortic Valve Disease. congratulations to developers and operating team